source · application/json
source_f2d0598103844df9
sha256 19eefd263f9b21bc2841457b3f9e3171bbf7244073ae8bcaab120171d701a064
by researka:v2 · 2026-06-20 09:29:06.102000+04:00
{"content_hash": "sha256:502cd1ce3ef846a621dd0bc5afea4c8169adde253b80ccfc967743f2c0dce277", "edges": [{"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_1", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_2", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_3", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_4", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_5", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_6", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_7", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_8", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_9", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_10", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_11", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_12", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_13", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_14", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_15", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_16", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_17", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_18", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_19", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_20", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_21", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_22", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_23", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_24", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_25", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_26", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_27", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_28", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_29", "type": "contains_claim"}, {"from": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "to": "claim_30", "type": "contains_claim"}], "nodes": [{"id": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "title": "Research Synthesis: EGCG green tea longevity — full paper", "type": "publication"}, {"id": "claim_1", "text": "Evidence-honesty note: 64/78 retained sources are coded as null or no extracted directional signal; this corpus is non-supportive for clinical efficacy claims and hypothesis-generating only. Source-bundle reconciliation note: Directional coding is conservative claim-level coding from extracted claim records, not a statement that the source texts contain no directional findings; source-level positive, negative, or unclear findings should be interpreted through the coded outcome class, directness, and claim-count fields. 74/78 retained sources are indirect, review-level, adjacent, or mechanistic and are used only to bound interpretation. The conclusion therefore does not support broad causal, clinical, or policy claims.", "type": "claim"}, {"id": "claim_2", "text": "Epigallocatechin gallate (EGCG), the dominant catechin in green tea, has attracted substantial interest as a candidate geroprotector, with proposed mechanisms spanning mitochondrial complex I inhibition, anti-inflammatory signaling, and bone-metabolic effects, yet the human evidence base remains fragmented across preclinical, mechanistic, and trial designs.", "type": "claim"}, {"id": "claim_3", "text": "We conducted an AI-assisted structured evidence synthesis with full audit trail, screening 78 curated references across direct human RCTs, mechanistic/preclinical studies, and indirect observational evidence, and resolving each into a canonical outcome class to prevent cross-domain fusion.", "type": "claim"}, {"id": "claim_4", "text": "Across the corpus, the evidence supports a hedged position: EGCG-rich green tea is mechanistically plausible and biomarker-active in select human RCTs, but no included source directly demonstrates lifespan or functional-longevity extension in humans, so the anti-aging case remains incomplete until adequately powered, hard-outcome trials are completed.", "type": "claim"}, {"id": "claim_5", "text": "Evidence-abstraction note.** The 78 retained reference papers are not 78 independent primary clinical trials: 74 are review, indirect, mechanistic, or registered-protocol source-level summaries, and 4 are classified as direct interventional evidence. Interpretation below therefore separates primary clinical-trial evidence from review-level, preclinical, and other indirect evidence.", "type": "claim"}, {"id": "claim_6", "text": "This synthesis evaluates evidence on EGCG green tea longevity across 78 included source papers and 2351 high-confidence extracted claims. The review is organized around the distinction between direct interventional hard-endpoint evidence, indirect interventional hard-endpoint evidence, and mechanistic evidence so that biological plausibility is not confused with clinical certainty.", "type": "claim"}, {"id": "claim_7", "text": "The corpus contains 4 direct clinical sources, 51 adjacent clinical sources, and 23 mechanistic or model-system sources. That distribution makes the synthesis appropriate for evaluating convergence, boundary conditions, and trial-design implications, while requiring caution around any conclusion that would exceed the direct human evidence.", "type": "claim"}, {"id": "claim_8", "text": "The thesis is: Across 78 curated reference papers, the evidence base for Egcg shows a context-dependent profile. Positive signals appear in: dosing pharmacokinetics, mechanism. Negative signals appear in: cardiometabolic. Null findings dominate: contextual other, mechanism. The synthesis surfaces cross-study disagreements across outcome classes — see Cross-Domain Synthesis. The Egcg anti-aging case as currently constituted is incomplete: mechanistic plausibility coexists with mixed or sparse human-RCT evidence, and the boundary conditions remain to be established. This thesis is treated as an organizing claim, not as a substitute for the study table, because the source record includes supportive, null, and adverse signals across different outcome classes.", "type": "claim"}, {"id": "claim_9", "text": "This distinction matters for publication because it makes the paper falsifiable. A future source can strengthen, weaken, or reverse the synthesis by changing the evidence tier, direction, or outcome-class balance.", "type": "claim"}, {"id": "claim_10", "text": "The mechanistic layer is most useful when it explains why a trial signal might appear or fail to appear. It is weaker when it is used as a replacement for outcome data, so this synthesis treats it as interpretive support rather than independent clinical proof.", "type": "claim"}, {"id": "claim_11", "text": "Null findings have a specific role in this evidence model. They do not erase mechanistic plausibility, but they do narrow the set of claims that can be made about effect consistency, target population, and endpoint selection.", "type": "claim"}, {"id": "claim_12", "text": "Adverse or negative signals are likewise retained in the main interpretation. For an aging intervention, the risk profile is part of the efficacy question because a plausible mechanism is not sufficient if the same corpus shows offsetting harm or tolerability constraints.", "type": "claim"}, {"id": "claim_13", "text": "The evidence base also distinguishes breadth from certainty. A broad corpus can cover many biological domains while still leaving the clinically decisive question unresolved if direct evidence is limited, heterogeneous, or endpoint-specific.", "type": "claim"}, {"id": "claim_14", "text": "Several methodological and design questions cut across the Egcg evidence base and warrant explicit framing. First, endpoint choice remains unsettled: most trials rely on cardiometabolic, inflammatory, or cognitive biomarkers, whose surrogate status is a recognized limitation (Ioannidis 2005), and no trial has been designed around canonical geroscience endpoints tied to the 0.8 m/s gait-speed threshold (Studenski 2011), the 0.6 m/s severe-frailty marker (Cesari 2009), the 0.1 m/s clinically meaningful change (Perera 2006), the EWGSOP2 grip-strength cutoffs of 27 kg (men) and 16 kg (women) (Cruz-Jentoft 2019), or the approximate 0.05 m/s annual age-related gait-speed decline (Bohannon 1997). Second, heterogeneity in EGCG formulation (decaffeinated extract vs isolated EGCG), dosing tier, and co-interventions (multimodal lifestyle, periodontal scaling, dietary background) limits cross-trial comparability, a problem compounded by variation in habitual green tea consumption across study populations. Third, treatment duration and follow-up in current trials are short relative to the chronicity of aging phenotypes, raising the question of whether exposure windows of weeks can be expected to move endpoints that evolve over years. Finally, concurrent interventions in trials such as PENSA, where multimodal lifestyle is bundled with EGCG, confound attribution of benefit and complicate any Egcg claim. Resolving these questions will require trials of longer duration, in older populations at defined frailty or sarcopenia thresholds, with composite endpoints that integrate the hallmark framework rather than a single surrogate.", "type": "claim"}, {"id": "claim_15", "text": "The biological rationale is treated as context rather than as clinical proof. Population fit, comparator alignment, clinical directness, follow-up length, ascertainment method, baseline risk, adherence, exposure dose, and external validity are kept separate during interpretation. The interpretation", "type": "claim"}, {"id": "claim_16", "text": "The following fields were extracted from each included source: study design, population / cohort, intervention or exposure, comparator, outcome class, effect direction, effect size, confidence interval or credible interval, p-value, sample size, follow-up duration, risk-of-bias rating. Under the calibration rule, source verification in the public bundle is limited to reference-level metadata; exact statistics and effect directions are drawn from these structured extraction artifacts (the synthesis manifest, risk-of-bias appraisal, and claim registry) rather than from re-parsed full text.", "type": "claim"}, {"id": "claim_17", "text": "Per-source risk-of-bias was rated using design-appropriate Cochrane RoB-2 (RCTs), ROBINS-I (non-randomised studies), and AMSTAR-2 (systematic reviews / meta-analyses).", "type": "claim"}, {"id": "claim_18", "text": "Evidence-tension synthesis: claims grouped by outcome class (cardiometabolic, contextual adjacent evidence, deficiency prevalence, dosing and pharmacokinetics, immune and inflammation, longevity, mechanism, muscle function, safety and comorbidity, skeletal, fracture, and bone); within-class agreement, disagreement, and directness gaps surfaced explicitly. Quantitative pooling applied only where ≥3 sources reported a comparable endpoint with extractable effect estimates.", "type": "claim"}, {"id": "claim_19", "text": "Source retrieval, claim extraction, evidence routing, and prose drafting were assisted by large language models under a deterministic audit-trail protocol. Every manuscript claim is traceable to a source record in the supplementary `manifest.json`. Final eligibility and interpretation decisions are author-verified.", "type": "claim"}, {"id": "claim_20", "text": "| Evidence domain | Corpus slice | Strongest signal | Directness | Main limitation |", "type": "claim"}, {"id": "claim_21", "text": "| Contextual Adjacent Evidence | n=43; claims=1381 | no extracted directional signal in 38/43 sources | 2 direct; 39 indirect; 1 protocol; 1 review | limited corpus depth in this outcome class |", "type": "claim"}, {"id": "claim_22", "text": "Outcome-class note:** Contextual Adjacent Evidence denotes background, boundary-condition, or adjacent-outcome sources. It is not pooled with direct outcome evidence; these sources bound scope, safety, methods, and translation rather than serving as equal-weight support for the main efficacy claim.", "type": "claim"}, {"id": "claim_23", "text": "Contextual Adjacent Evidence: n=43; claims=1381; no extracted directional signal in 38/43 sources | directness: 2 direct; 39 indirect; 1 review; 1 protocol; main limitation: directionally heterogeneous.", "type": "claim"}, {"id": "claim_24", "text": "One clinical RCT in adults constitutes the only direct human evidence for the cardiometabolic outcome class in the curated corpus. The trial is the only source bearing a direct clinical/functional designation for cardiometabolic outcomes in this synthesis.", "type": "claim"}, {"id": "claim_25", "text": "The corpus on EGCG and green tea is dominated by mechanistic and indirect-evidence strands, with a comparatively narrow clinical RCT spine.", "type": "claim"}, {"id": "claim_26", "text": "Additional corpus sources included animal/preclinical evidence; within this contextual class, quantitative signals are heterogeneous. Pharmacokinetic compartmental modeling in Hodges 2023 reports residence-time effects with P < 0.001 and P < 0.0001 for gallated versus non-gallated catechin trafficking in healthy adults. Conversely, several indirect reports recorded predominantly null effects in their primary endpoints: Zuo 2025 on CYP450 regulation in HepG2 cells (P < 0.01, P < 0.05, but null for several contrasts), Du 2012 in chemoprevention comparisons, and Xu 2020 in the 4T1 breast-cancer MDSC model.", "type": "claim"}, {"id": "claim_27", "text": "Mechanistically, the contextual corpus sketches a converging but incomplete substrate for any longevity claim. Pharmacokinetic compartmental modeling (Hodges 2023) and gut-microbiota–mediated catechin transformation (Su 2024, P < 0.05) provide bioavailability and metabolic-route context. The mechanistic substrate underlying any functional longevity finding therefore coexists with reproducibly null indirect observations across large segments of the contextual literature.", "type": "claim"}, {"id": "claim_28", "text": "Within-corpus tensions are most visible along two axes. First, the indirectness gap between the two direct RCTs (Iino 2026, Zeng 2022) and the predominantly indirect remainder creates an evidence-asymmetry that the prose above already separates by design stratum. Second, the null vs positive tension between Rasheed 2009 (positive on contextual other) and the large null-leaning indirect block (Du 2012, Gu 2013, Baker 2015, Bae 2017, Khan 2018, Bungau 2019, Hengge 2019, Pervin 2019, Ali 2019, Xu 2017, Heyza 2018, Park 2021b, Yap 2021, Kapoor 2021, Siriphap 2022, LeBlanc 2022, Mokra 2022, Urdzikova 2023, Li 2026, Zuo 2025, Yang 2025b, Quan 2023, Ferrari 2025, Zhou 2025, Su 2024, Johnson 2025, Forcano 2025, Rovaldi 2025, Hodges 2023, Al-Hendy 2024, Agarwal 2023, Nesran 2019, Xu 2020, Miyoshi 2020, Almatroodi 2020, Huang 2020, Khurana 2013, Yi 2017, Aguilera 2023) is best read as a design-discordance rather than a contradiction: Rasheed 2009 is a tightly controlled in vitro chondrocyte study with mechanistic readouts, whereas most null reports are observational, narrative-review, or protocol-level with no enrolled clinical population. The cardiometabolic strand (Roberts 2021) is itself mixed-direction, and Iino 2026 reports divergent insulin-resistance improvement (P = 0.020) with no visceral-fat reduction (P = 0.243). These within-corpus disagreements imply that the EGCG-and-longevity case as currently constituted is incomplete and that boundary conditions — dose, gallation, host genotype, microbiome — remain to be established before clinical claims can be sharpened.", "type": "claim"}, {"id": "claim_29", "text": "Within the curated evidence base on EGCg (epigallocatechin gallate) and longevity, only one source — Sun 2019 — is mapped to the deficiency prevalence outcome class, and it is explicitly tagged as indirect rather than as a direct epidemiological or clinical prevalence study (Sun 2019). The population described in that source is framed generically as adults, and no p-values, hazard ratios, or sample-size numerics are reported in the available metadata (Sun 2019). Consequently, the corpus does not support a quantitative prevalence estimate for any EGCg-related deficiency state; the outcome class is populated by structural/biophysical work rather than by nutritional-epidemiology data (Sun 2019).", "type": "claim"}, {"id": "claim_30", "text": "These are reagent- and biophysics-level descriptors, not effect sizes, and the source contains no confidence intervals, p-values, or risk estimates that could be carried into a clinical-effectiveness synthesis (Sun 2019). As a result, the deficiency prevalence class contributes no clinically reportable effect estimate to the longevity case for EGCg (Sun 2019).", "type": "claim"}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3389/fnut.2025.1663800", "effect": "not extracted", "endpoint": "not extracted", "id": "source_1", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Investigation of the regulatory effects of tea polyphenols on CYP450s in HepG2 cells", "type": "source", "url": "https://doi.org/10.3389/fnut.2025.1663800", "year": 2025}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/nu13030764", "effect": "not extracted", "endpoint": "not extracted", "id": "source_2", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "The Impact of Decaffeinated Green Tea Extract on Fat Oxidation, Body Composition and Cardio-Metabolic Health in Overweight, Recreationally Active Individuals", "type": "source", "url": "https://doi.org/10.3390/nu13030764", "year": 2021}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1186/s40168-021-01115-9", "effect": "not extracted", "endpoint": "not extracted", "id": "source_3", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis", "type": "source", "url": "https://doi.org/10.1186/s40168-021-01115-9", "year": 2021}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/antiox12020363", "effect": "not extracted", "endpoint": "not extracted", "id": "source_4", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "The Role of Green Tea Catechin Epigallocatechin Gallate (EGCG) and Mammalian Target of Rapamycin (mTOR) Inhibitor PP242 (Torkinib) in the Treatment of Spinal Cord Injury", "type": "source", "url": "https://doi.org/10.3390/antiox12020363", "year": 2023}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1016/j.tjpad.2025.100271", "effect": "not extracted", "endpoint": "not extracted", "id": "source_5", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "A multimodal lifestyle intervention complemented with epigallocatechin gallate to prevent cognitive decline in APOE - ɛ4 carriers with Subjective Cognitive Decline: a randomized, double-blinded clinical trial (PENSA study)", "type": "source", "url": "https://doi.org/10.1016/j.tjpad.2025.100271", "year": 2025}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/biomedicines11030789", "effect": "not extracted", "endpoint": "not extracted", "id": "source_6", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Epigallocatechin Gallate (EGCG), an Active Phenolic Compound of Green Tea, Inhibits Tumor Growth of Head and Neck Cancer Cells by Targeting DNA Hypermethylation", "type": "source", "url": "https://doi.org/10.3390/biomedicines11030789", "year": 2023}, {"comparator": "not extracted", "directness": "primary", "doi": "10.18632/aging.203597", "effect": "not extracted", "endpoint": "not extracted", "id": "source_7", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Green tea catechins EGCG and ECG enhance the fitness and lifespan of Caenorhabditis elegans by complex I inhibition", "type": "source", "url": "https://doi.org/10.18632/aging.203597", "year": 2021}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/biom10040620", "effect": "not extracted", "endpoint": "not extracted", "id": "source_8", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Green Tea Catechin (-)-Epigallocatechin-3-Gallate (EGCG) Facilitates Fracture Healing", "type": "source", "url": "https://doi.org/10.3390/biom10040620", "year": 2020}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1155/2022/6773662", "effect": "not extracted", "endpoint": "not extracted", "id": "source_9", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Painful Diabetic Neuropathy Is Associated with Compromised Microglial IGF-1 Signaling Which Can Be Rescued by Green Tea Polyphenol EGCG in Mice", "type": "source", "url": "https://doi.org/10.1155/2022/6773662", "year": 2022}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1038/s41598-024-72269-3", "effect": "not extracted", "endpoint": "not extracted", "id": "source_10", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Epigallocatechin gallate enhances sympathetic heart rate variability and decreases blood pressure in obese subjects: a randomized control trial", "type": "source", "url": "https://doi.org/10.1038/s41598-024-72269-3", "year": 2024}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/nu18050851", "effect": "not extracted", "endpoint": "not extracted", "id": "source_11", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Green Tea Catechin Plus Inulin Improves Insulin Resistance Without Reducing Visceral Fat and Shows Exploratory Gut Microbiota Signals in Adults with Visceral Obesity: A Double-Blind Randomized Controlled Trial", "type": "source", "url": "https://doi.org/10.3390/nu18050851", "year": 2026}, {"comparator": "not extracted", "directness": "review-level", "doi": "10.3390/molecules26123702", "effect": "not extracted", "endpoint": "not extracted", "id": "source_12", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Green Tea Catechin Association with Ultraviolet Radiation-Induced Erythema: A Systematic Review and Meta-Analysis", "type": "source", "url": "https://doi.org/10.3390/molecules26123702", "year": 2021}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1186/s13063-022-06298-6", "effect": "not extracted", "endpoint": "not extracted", "id": "source_13", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "The effect of (-)-epigallocatechin gallate as an adjunct to non-surgical periodontal treatment: a randomized clinical trial", "type": "source", "url": "https://doi.org/10.1186/s13063-022-06298-6", "year": 2022}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/ijms23063165", "effect": "not extracted", "endpoint": "not extracted", "id": "source_14", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Adipose-Derived Stem Cells Preincubated with Green Tea EGCG Enhance Pancreatic Tissue Regeneration in Rats with Type 1 Diabetes through ROS/Sirt1 Signaling Regulation", "type": "source", "url": "https://doi.org/10.3390/ijms23063165", "year": 2022}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/nu15184021", "effect": "not extracted", "endpoint": "not extracted", "id": "source_15", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Gallation and B-Ring Dihydroxylation Increase Green Tea Catechin Residence Time in Plasma by Differentially Affecting Tissue-Specific Trafficking: Compartmental Model of Catechin Kinetics in Healthy Adults", "type": "source", "url": "https://doi.org/10.3390/nu15184021", "year": 2023}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/nu12102949", "effect": "not extracted", "endpoint": "not extracted", "id": "source_16", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Effects of Standardized Green Tea Extract and Its Main Component, EGCG, on Mitochondrial Function and Contractile Performance of Healthy Rat Cardiomyocytes", "type": "source", "url": "https://doi.org/10.3390/nu12102949", "year": 2020}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1038/s41538-025-00601-w", "effect": "not extracted", "endpoint": "not extracted", "id": "source_17", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Administration of green tea polyphenols mitigates iron-overload-induced bone loss in a β-thalassemia mouse model", "type": "source", "url": "https://doi.org/10.1038/s41538-025-00601-w", "year": 2025}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/antibiotics11040518", "effect": "not extracted", "endpoint": "not extracted", "id": "source_18", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Antimicrobial Activity of the Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate (EGCG) against Clinical Isolates of Multidrug-Resistant Vibrio cholerae", "type": "source", "url": "https://doi.org/10.3390/antibiotics11040518", "year": 2022}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1111/cts.70189", "effect": "not extracted", "endpoint": "not extracted", "id": "source_19", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Evaluating the Effect of Epigallocatechin Gallate (EGCG) in Reducing Folate Levels in Reproductive Aged Women by MTHFR and DHFR Genotype in Combination With Letrozole or Clomiphene", "type": "source", "url": "https://doi.org/10.1111/cts.70189", "year": 2025}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3389/fphar.2021.628526", "effect": "not extracted", "endpoint": "not extracted", "id": "source_20", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Epigallocatechin-3-Gallate, the Main Polyphenol in Green Tea, Inhibits Porcine Epidemic Diarrhea Virus In Vitro", "type": "source", "url": "https://doi.org/10.3389/fphar.2021.628526", "year": 2021}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/v15010151", "effect": "not extracted", "endpoint": "not extracted", "id": "source_21", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Effect of EGCG Extracted from Green Tea against Largemouth Bass Virus Infection", "type": "source", "url": "https://doi.org/10.3390/v15010151", "year": 2023}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/foods15101732", "effect": "not extracted", "endpoint": "not extracted", "id": "source_22", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "In Vitro Fermentation of Green Tea by Human Gut Microbiota Enhances Bioactivity and Bidirectionally Modulates Polyphenol Metabolites and Gut Microbiota", "type": "source", "url": "https://doi.org/10.3390/foods15101732", "year": 2026}, {"comparator": "not extracted", "directness": "primary", "doi": "10.4103/jisp.jisp_168_22", "effect": "not extracted", "endpoint": "not extracted", "id": "source_23", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "“Efficacy of cytotoxic effect of green tea catechins on the human periodontal fibroblasts and human dental pulp fibroblasts -An in vitro study”", "type": "source", "url": "https://doi.org/10.4103/jisp.jisp_168_22", "year": 2023}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1111/cpr.13289", "effect": "not extracted", "endpoint": "not extracted", "id": "source_24", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "3D printed PCLA scaffold with nano‐hydroxyapatite coating doped green tea EGCG promotes bone growth and inhibits multidrug‐resistant bacteria colonization", "type": "source", "url": "https://doi.org/10.1111/cpr.13289", "year": 2022}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1136/bmjopen-2023-078989", "effect": "not extracted", "endpoint": "not extracted", "id": "source_25", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Fibroids and unexplained infertility treatment with epigallocatechin gallate: a natural compound in green tea (FRIEND) – protocol for a randomised placebo-controlled US multicentre clinical trial of EGCG to improve fertility in women with uterine fibroids", "type": "source", "url": "https://doi.org/10.1136/bmjopen-2023-078989", "year": 2024}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/antiox13020158", "effect": "not extracted", "endpoint": "not extracted", "id": "source_26", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "EGCG, a Green Tea Compound, Increases NO Production and Has Antioxidant Action in a Static and Shear Stress In Vitro Model of Preeclampsia", "type": "source", "url": "https://doi.org/10.3390/antiox13020158", "year": 2024}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/cells12111448", "effect": "not extracted", "endpoint": "not extracted", "id": "source_27", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Spontaneous Osteogenic Differentiation of Human Mesenchymal Stem Cells by Tuna-Bone-Derived Hydroxyapatite Composites with Green Tea Polyphenol-Reduced Graphene Oxide", "type": "source", "url": "https://doi.org/10.3390/cells12111448", "year": 2023}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/molecules30153128", "effect": "not extracted", "endpoint": "not extracted", "id": "source_28", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Catechins and Human Health: Breakthroughs from Clinical Trials", "type": "source", "url": "https://doi.org/10.3390/molecules30153128", "year": 2025}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/foods13050792", "effect": "not extracted", "endpoint": "not extracted", "id": "source_29", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Microbial-Transferred Metabolites and Improvement of Biological Activities of Green Tea Catechins by Human Gut Microbiota", "type": "source", "url": "https://doi.org/10.3390/foods13050792", "year": 2024}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/nu12041042", "effect": "not extracted", "endpoint": "not extracted", "id": "source_30", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Green Tea Polyphenol EGCG Attenuates MDSCs-mediated Immunosuppression through Canonical and Non-Canonical Pathways in a 4T1 Murine Breast Cancer Model", "type": "source", "url": "https://doi.org/10.3390/nu12041042", "year": 2020}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/cimb46080531", "effect": "not extracted", "endpoint": "not extracted", "id": "source_31", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Green Tea Polyphenol (-)-Epicatechin Pretreatment Mitigates Hepatic Steatosis in an In Vitro MASLD Model", "type": "source", "url": "https://doi.org/10.3390/cimb46080531", "year": 2024}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/v13122533", "effect": "not extracted", "endpoint": "not extracted", "id": "source_32", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Epigallocatechin Gallate (EGCG), a Green Tea Polyphenol, Reduces Coronavirus Replication in a Mouse Model", "type": "source", "url": "https://doi.org/10.3390/v13122533", "year": 2021}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1155/2020/7958041", "effect": "not extracted", "endpoint": "not extracted", "id": "source_33", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Iron Chelation Properties of Green Tea Epigallocatechin-3-Gallate (EGCG) in Colorectal Cancer Cells: Analysis on Tfr/Fth Regulations and Molecular Docking", "type": "source", "url": "https://doi.org/10.1155/2020/7958041", "year": 2020}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/molecules25122853", "effect": "not extracted", "endpoint": "not extracted", "id": "source_34", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Epigallocatechin-3-Gallate (EGCG), an Active Compound of Green Tea Attenuates Acute Lung Injury Regulating Macrophage Polarization and Krüpple-Like-Factor 4 (KLF4) Expression", "type": "source", "url": "https://doi.org/10.3390/molecules25122853", "year": 2020}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/antiox11020294", "effect": "not extracted", "endpoint": "not extracted", "id": "source_35", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Assessment of Antioxidant, Immunomodulatory Activity of Oxidised Epigallocatechin-3-Gallate (Green Tea Polyphenol) and Its Action on the Main Protease of SARS-CoV-2—An In Vitro and In Silico Approach", "type": "source", "url": "https://doi.org/10.3390/antiox11020294", "year": 2022}, {"comparator": "not extracted", "directness": "review-level", "doi": "10.1186/s12885-025-15516-8", "effect": "not extracted", "endpoint": "not extracted", "id": "source_36", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Green tea catechins and prostate cancer: mechanisms, clinical evidence, and safety: a narrative review", "type": "source", "url": "https://doi.org/10.1186/s12885-025-15516-8", "year": 2026}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/pathogens10040459", "effect": "not extracted", "endpoint": "not extracted", "id": "source_37", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "The Major Constituent of Green Tea, Epigallocatechin-3-Gallate (EGCG), Inhibits the Growth of HPV18-Infected Keratinocytes by Stimulating Proteasomal Turnover of the E6 and E7 Oncoproteins", "type": "source", "url": "https://doi.org/10.3390/pathogens10040459", "year": 2021}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/antiox10071076", "effect": "not extracted", "endpoint": "not extracted", "id": "source_38", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Green Tea and Epigallocatechin Gallate (EGCG) for the Management of Nonalcoholic Fatty Liver Diseases (NAFLD): Insights into the Role of Oxidative Stress and Antioxidant Mechanism", "type": "source", "url": "https://doi.org/10.3390/antiox10071076", "year": 2021}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1097/MD.0000000000044070", "effect": "not extracted", "endpoint": "not extracted", "id": "source_39", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Integrating network pharmacology, bioinformatics and molecular docking to explore the anti-NSCLC mechanisms of EGCG in green tea", "type": "source", "url": "https://doi.org/10.1097/MD.0000000000044070", "year": 2025}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/ijms26189253", "effect": "not extracted", "endpoint": "not extracted", "id": "source_40", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Epigallocatechin-Gallate (EGCG): An Essential Molecule for Human Health and Well-Being", "type": "source", "url": "https://doi.org/10.3390/ijms26189253", "year": 2025}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/molecules28217262", "effect": "not extracted", "endpoint": "not extracted", "id": "source_41", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "The Green Tea Polyphenol Epigallocatechin-Gallate (EGCG) Interferes with Microcin E492 Amyloid Formation", "type": "source", "url": "https://doi.org/10.3390/molecules28217262", "year": 2023}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/molecules25112588", "effect": "not extracted", "endpoint": "not extracted", "id": "source_42", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Applications of a Standardized Green Tea Catechin Preparation for Viral Warts and Human Papilloma Virus-Related and Unrelated Cancers", "type": "source", "url": "https://doi.org/10.3390/molecules25112588", "year": 2020}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1038/s41598-022-17088-0", "effect": "not extracted", "endpoint": "not extracted", "id": "source_43", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "The green tea catechin EGCG provides proof-of-concept for a pan-coronavirus attachment inhibitor", "type": "source", "url": "https://doi.org/10.1038/s41598-022-17088-0", "year": 2022}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/molecules26123572", "effect": "not extracted", "endpoint": "not extracted", "id": "source_44", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Significant Inactivation of SARS-CoV-2 In Vitro by a Green Tea Catechin, a Catechin-Derivative, and Black Tea Galloylated Theaflavins", "type": "source", "url": "https://doi.org/10.3390/molecules26123572", "year": 2021}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/antiox11081566", "effect": "not extracted", "endpoint": "not extracted", "id": "source_45", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG): A Time for a New Player in the Treatment of Respiratory Diseases?", "type": "source", "url": "https://doi.org/10.3390/antiox11081566", "year": 2022}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/nu17071101", "effect": "not extracted", "endpoint": "not extracted", "id": "source_46", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Research Progress on the Protective Effect of Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG) on the Liver", "type": "source", "url": "https://doi.org/10.3390/nu17071101", "year": 2025}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1002/pdi3.7", "effect": "not extracted", "endpoint": "not extracted", "id": "source_47", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "A green tea extract catechin EGCg: Therapeutic potential for pediatric cardiomyopathies", "type": "source", "url": "https://doi.org/10.1002/pdi3.7", "year": 2023}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/life11030197", "effect": "not extracted", "endpoint": "not extracted", "id": "source_48", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Therapeutic Potential of EGCG, a Green Tea Polyphenol, for Treatment of Coronavirus Diseases", "type": "source", "url": "https://doi.org/10.3390/life11030197", "year": 2021}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1080/07853890.2026.2634566", "effect": "not extracted", "endpoint": "not extracted", "id": "source_49", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Epigenetic regulators polyphenols in neurodegenerative diseases: a promising intervention strategy", "type": "source", "url": "https://doi.org/10.1080/07853890.2026.2634566", "year": 2026}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1016/j.advnut.2025.100545", "effect": "not extracted", "endpoint": "not extracted", "id": "source_50", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Tea Polyphenol Epigallocatechin Gallate and the Gut–Health Axis: Unraveling Structural Characteristics, Metabolic Pathways, and Systemic Benefits", "type": "source", "url": "https://doi.org/10.1016/j.advnut.2025.100545", "year": 2025}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/molecules26051200", "effect": "not extracted", "endpoint": "not extracted", "id": "source_51", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "EGCG, a Green Tea Catechin, as a Potential Therapeutic Agent for Symptomatic and Asymptomatic SARS-CoV-2 Infection", "type": "source", "url": "https://doi.org/10.3390/molecules26051200", "year": 2021}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/antiox9111136", "effect": "not extracted", "endpoint": "not extracted", "id": "source_52", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Osteoprotective Roles of Green Tea Catechins", "type": "source", "url": "https://doi.org/10.3390/antiox9111136", "year": 2020}, {"comparator": "not extracted", "directness": "primary", "doi": "10.2903/j.efsa.2018.5239", "effect": "not extracted", "endpoint": "not extracted", "id": "source_53", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Scientific opinion on the safety of green tea catechins", "type": "source", "url": "https://doi.org/10.2903/j.efsa.2018.5239", "year": 2018}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1186/2045-824X-5-9", "effect": "not extracted", "endpoint": "not extracted", "id": "source_54", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1α and NFκB, and VEGF expression", "type": "source", "url": "https://doi.org/10.1186/2045-824X-5-9", "year": 2013}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/nu10050569", "effect": "not extracted", "endpoint": "not extracted", "id": "source_55", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "A Randomized, Placebo-Controlled Study on the Safety and Efficacy of Daily Ingestion of Green Tea ( Camellia sinensis L.) cv. “Yabukita” and “Sunrouge” on Eyestrain and Blood Pressure in Healthy Adults", "type": "source", "url": "https://doi.org/10.3390/nu10050569", "year": 2018}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/nu4111679", "effect": "not extracted", "endpoint": "not extracted", "id": "source_56", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Epigallocatechin Gallate (EGCG) Is the Most Effective Cancer Chemopreventive Polyphenol in Green Tea", "type": "source", "url": "https://doi.org/10.3390/nu4111679", "year": 2012}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1038/s41598-017-06879-5", "effect": "not extracted", "endpoint": "not extracted", "id": "source_57", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Hydrogen sulphide donors selectively potentiate a green tea polyphenol EGCG-induced apoptosis of multiple myeloma cells", "type": "source", "url": "https://doi.org/10.1038/s41598-017-06879-5", "year": 2017}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1038/s41598-019-40328-9", "effect": "not extracted", "endpoint": "not extracted", "id": "source_58", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Prenatal treatment with EGCG enriched green tea extract rescues GAD67 related developmental and cognitive defects in Down syndrome mouse models", "type": "source", "url": "https://doi.org/10.1038/s41598-019-40328-9", "year": 2019}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/molecules170910355", "effect": "not extracted", "endpoint": "not extracted", "id": "source_59", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "The Dual Action of Epigallocatechin Gallate (EGCG), the Main Constituent of Green Tea, against the Deleterious Effects of Visible Light and Singlet Oxygen-Generating Conditions as Seen in Yeast Cells", "type": "source", "url": "https://doi.org/10.3390/molecules170910355", "year": 2012}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1155/2015/163591", "effect": "not extracted", "endpoint": "not extracted", "id": "source_60", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Green Tea Catechin, EGCG, Suppresses PCB 102-Induced Proliferation in Estrogen-Sensitive Breast Cancer Cells", "type": "source", "url": "https://doi.org/10.1155/2015/163591", "year": 2015}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1186/ar2700", "effect": "not extracted", "endpoint": "not extracted", "id": "source_61", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Green tea polyphenol epigallocatechin-3-gallate inhibits advanced glycation end product-induced expression of tumor necrosis factor-α and matrix metalloproteinase-13 in human chondrocytes", "type": "source", "url": "https://doi.org/10.1186/ar2700", "year": 2009}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1155/2019/3480569", "effect": "not extracted", "endpoint": "not extracted", "id": "source_62", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Induction of Endoplasmic Reticulum Stress Pathway by Green Tea Epigallocatechin-3-Gallate (EGCG) in Colorectal Cancer Cells: Activation of PERK/p-eIF2 α /ATF4 and IRE1 α", "type": "source", "url": "https://doi.org/10.1155/2019/3480569", "year": 2019}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1155/2017/9032792", "effect": "not extracted", "endpoint": "not extracted", "id": "source_63", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Green Tea Polyphenols Ameliorate the Early Renal Damage Induced by a High-Fat Diet via Ketogenesis/SIRT3 Pathway", "type": "source", "url": "https://doi.org/10.1155/2017/9032792", "year": 2017}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/ijms20205081", "effect": "not extracted", "endpoint": "not extracted", "id": "source_64", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Green Tea Polyphenol (−)-Epigallocatechin Gallate (EGCG) Attenuates Neuroinflammation in Palmitic Acid-Stimulated BV-2 Microglia and High-Fat Diet-Induced Obese Mice", "type": "source", "url": "https://doi.org/10.3390/ijms20205081", "year": 2019}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1155/2019/6154170", "effect": "not extracted", "endpoint": "not extracted", "id": "source_65", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Protein Binding Characteristics of the Principal Green Tea Catechins: A QCM Study Comparing Crude Extract to Pure EGCG", "type": "source", "url": "https://doi.org/10.1155/2019/6154170", "year": 2019}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/ijms161226081", "effect": "not extracted", "endpoint": "not extracted", "id": "source_66", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Application of Green Tea Catechin for Inducing the Osteogenic Differentiation of Human Dedifferentiated Fat Cells in Vitro", "type": "source", "url": "https://doi.org/10.3390/ijms161226081", "year": 2015}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/ijms20153630", "effect": "not extracted", "endpoint": "not extracted", "id": "source_67", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Function of Green Tea Catechins in the Brain: Epigallocatechin Gallate and its Metabolites", "type": "source", "url": "https://doi.org/10.3390/ijms20153630", "year": 2019}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/nu10111644", "effect": "not extracted", "endpoint": "not extracted", "id": "source_68", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells", "type": "source", "url": "https://doi.org/10.3390/nu10111644", "year": 2018}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/nu5103779", "effect": "not extracted", "endpoint": "not extracted", "id": "source_69", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Polyphenols: Benefits to the Cardiovascular System in Health and in Aging", "type": "source", "url": "https://doi.org/10.3390/nu5103779", "year": 2013}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/biom9110705", "effect": "not extracted", "endpoint": "not extracted", "id": "source_70", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Conformation and Aggregation of Human Serum Albumin in the Presence of Green Tea Polyphenol (EGCg) and/or Palmitic Acid", "type": "source", "url": "https://doi.org/10.3390/biom9110705", "year": 2019}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1096/fasebj.22.1_supplement.702.9", "effect": "not extracted", "endpoint": "not extracted", "id": "source_71", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "The green tea polyphenol, (−)‐epigallocatechin‐3‐gallate, inhibits obesity and metabolic syndrome in high‐fat fed mice", "type": "source", "url": "https://doi.org/10.1096/fasebj.22.1_supplement.702.9", "year": 2008}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1155/2019/9783429", "effect": "not extracted", "endpoint": "not extracted", "id": "source_72", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Health Benefits of Polyphenols and Carotenoids in Age-Related Eye Diseases", "type": "source", "url": "https://doi.org/10.1155/2019/9783429", "year": 2019}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/molecules23061295", "effect": "not extracted", "endpoint": "not extracted", "id": "source_73", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "In Vitro and In Silico Studies of the Molecular Interactions of Epigallocatechin-3- O -gallate (EGCG) with Proteins That Explain the Health Benefits of Green Tea", "type": "source", "url": "https://doi.org/10.3390/molecules23061295", "year": 2018}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/nu11010039", "effect": "not extracted", "endpoint": "not extracted", "id": "source_74", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Tea Polyphenols in Promotion of Human Health", "type": "source", "url": "https://doi.org/10.3390/nu11010039", "year": 2018}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1038/srep22128", "effect": "not extracted", "endpoint": "not extracted", "id": "source_75", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "EGCG in Green Tea Induces Aggregation of HMGB1 Protein through Large Conformational Changes with Polarized Charge Redistribution", "type": "source", "url": "https://doi.org/10.1038/srep22128", "year": 2016}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/molecules24132403", "effect": "not extracted", "endpoint": "not extracted", "id": "source_76", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Targeting Bacterial Biofilms by the Green Tea Polyphenol EGCG", "type": "source", "url": "https://doi.org/10.3390/molecules24132403", "year": 2019}, {"comparator": "not extracted", "directness": "primary", "doi": "10.3390/molecules22081337", "effect": "not extracted", "endpoint": "not extracted", "id": "source_77", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "A Review of the Antiviral Role of Green Tea Catechins", "type": "source", "url": "https://doi.org/10.3390/molecules22081337", "year": 2017}, {"comparator": "not extracted", "directness": "review-level", "doi": "10.14295/bds.2016.v19i4.1316", "effect": "not extracted", "endpoint": "not extracted", "id": "source_78", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Effect of chlorhexidine, green tea and egcg as therapeutic primers to increase the durability of resin-dentin bond", "type": "source", "url": "https://doi.org/10.14295/bds.2016.v19i4.1316", "year": 2016}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_79", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "**Outcome class** is assigned from the source's bound endpoint, population, and claim text; adjacent/background sources are separated from clinical outcome slices.", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_80", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "**Directness** is coded as direct only when a source tests the topic against a clinically proximate outcome in the relevant population; a qualifying direct source would be a human interventional or hard-endpoint study of the topic itself. Indirect human, review-level, and mechanistic sources are weighted separately.", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_81", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "**Directional signal** is counted within the assigned outcome class only. A `no extracted directional signal` cell means the retained sources in that outcome slice did not yield a coded positive, negative, or mixed direction for that slice; it is not a claim that the source reports no associations anywhere else.", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_82", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "**Evidence tier** follows the deterministic tier/directness taxonomy used in the source builder; the prose writer cannot move a source between classes after sources are frozen.", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": "10.1001/jama.2010.1923", "effect": "not extracted", "endpoint": "not extracted", "id": "source_83", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Studenski 2011", "type": "source", "url": "https://doi.org/10.1001/jama.2010.1923", "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": "10.1093/gerona/glp012", "effect": "not extracted", "endpoint": "not extracted", "id": "source_84", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Cesari 2009", "type": "source", "url": "https://doi.org/10.1093/gerona/glp012", "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": "10.1111/j.1532-5415.2006.00701.x", "effect": "not extracted", "endpoint": "not extracted", "id": "source_85", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Perera 2006", "type": "source", "url": "https://doi.org/10.1111/j.1532-5415.2006.00701.x", "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_86", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "WHO 2000", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": "10.1093/ageing/26.1.15", "effect": "not extracted", "endpoint": "not extracted", "id": "source_87", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Bohannon 1997", "type": "source", "url": "https://doi.org/10.1093/ageing/26.1.15", "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": "10.1093/ageing/afy169", "effect": "not extracted", "endpoint": "not extracted", "id": "source_88", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Cruz-Jentoft 2019", "type": "source", "url": "https://doi.org/10.1093/ageing/afy169", "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_89", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Owen 2000", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": null, "effect": "not extracted", "endpoint": "not extracted", "id": "source_90", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Anisimov 2008", "type": "source", "url": null, "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": "10.1056/NEJM198812293192604", "effect": "not extracted", "endpoint": "not extracted", "id": "source_91", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Tinetti 1988", "type": "source", "url": "https://doi.org/10.1056/NEJM198812293192604", "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": "10.1056/NEJMoa1504347", "effect": "not extracted", "endpoint": "not extracted", "id": "source_92", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Tancredi 2015", "type": "source", "url": "https://doi.org/10.1056/NEJMoa1504347", "year": null}, {"comparator": "not extracted", "directness": "citation", "doi": "10.1371/journal.pmed.0020124", "effect": "not extracted", "endpoint": "not extracted", "id": "source_93", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Ioannidis 2005", "type": "source", "url": "https://doi.org/10.1371/journal.pmed.0020124", "year": null}], "publication_id": "894c8a6d-e240-4cf7-9da0-061b9f6a2380", "screening": {"excluded": 0, "exclusion_reasons": ["No PRISMA full-text exclusion-stage filter was applied."], "flow": ["identified", "screened", "excluded_with_reasons", "included"], "identified": 78, "included": 78, "included_or_retained": 78, "screened": 78, "wording": "78 candidate receipts retained after source retrieval, deduplication, and topic filtering. This is an evidence-map screening trace, not a PRISMA full-text exclusion audit."}}
metadata
{
"researka_object_type": "publication_sidecar",
"researka_publication_id": "894c8a6d-e240-4cf7-9da0-061b9f6a2380",
"researka_submission_id": "9ae401b0-b7a9-4bed-a6f5-76aec3eb781a",
"sidecar_name": "claim_graph.json",
"sidecar_url": "https://api.researka.org/publications/894c8a6d-e240-4cf7-9da0-061b9f6a2380/sidecars/claim_graph.json"
}